Treatment of hepatitis C in two paediatric patients using sofosbuvir during haematopoietic stem cell transplantation.
Journal
Antiviral therapy
ISSN: 2040-2058
Titre abrégé: Antivir Ther
Pays: England
ID NLM: 9815705
Informations de publication
Date de publication:
2019
2019
Historique:
accepted:
17
06
2019
pubmed:
12
9
2019
medline:
27
10
2020
entrez:
12
9
2019
Statut:
ppublish
Résumé
We report the first two paediatric cases of sofosbuvir treatment during high-intensity myeloablative conditioning and engraftment phases of haematopoietic stem cell transplantation. These reports highlight the safety of sofosbuvir during all phases of transplantation and the lack of interaction between sofosbuvir and alkylating or immunosuppressive agents.
Substances chimiques
Antiviral Agents
0
RNA, Viral
0
Ribavirin
49717AWG6K
Dasatinib
RBZ1571X5H
Sofosbuvir
WJ6CA3ZU8B
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM